Award recordCONTRACT

JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.

PIID 36C24722P0498· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $681,465 net obligations· UEI EQ4VSLH8RC33· FL

Description

EO 14398 DEI DISCRIMINATION

Base award description: CU-64 DOTATATE RADIO-PHARMACEUTICAL

First action · last action
2022-02-28 · 2026-07-16
Transactions
13
First transaction's obligation
$95,000
Base + all options value (sum of deltas)
$681,465
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$713,865$0Base award · 2022-02-28 · this action $95,000 · running total $95,000Modification P00001 · 2023-01-05 · this action $95,000 · running total $190,000Modification P00002 · 2023-10-26 · this action -$14,145 · running total $175,855Modification P00003 · 2023-11-07 · this action $97,200 · running total $273,055Modification P00004 · 2023-11-09 · this action $0 · running total $273,055Modification P00005 · 2024-05-30 · this action -$4,690 · running total $268,365Modification P00006 · 2024-10-15 · this action $101,250 · running total $369,615Modification P00007 · 2024-11-14 · this action $97,200 · running total $466,815Modification P00008 · 2025-05-01 · this action -$52,650 · running total $414,165Modification P00009 · 2025-09-23 · this action $101,250 · running total $515,415Modification P00010 · 2025-11-13 · this action $198,450 · running total $713,865Modification P00011 · 2026-06-16 · this action $0 · running total $713,865Modification P00012 · 2026-07-16 · this action -$32,400 · running total $681,465
  • Base2022-02-28+$95,000= $95,000
  • Mod P000012023-01-05+$95,000= $190,000
  • Mod P000022023-10-26-$14,145= $175,855
  • Mod P000032023-11-07+$97,200= $273,055
  • Mod P000042023-11-09+$0= $273,055
  • Mod P000052024-05-30-$4,690= $268,365
  • Mod P000062024-10-15+$101,250= $369,615
  • Mod P000072024-11-14+$97,200= $466,815
  • Mod P000082025-05-01-$52,650= $414,165
  • Mod P000092025-09-23+$101,250= $515,415
  • Mod P000102025-11-13+$198,450= $713,865
  • Mod P000112026-06-16+$0= $713,865
  • Mod P000122026-07-16-$32,400= $681,465
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-02-28+$95,000$95,000CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00001· EXERCISE AN OPTION2023-01-05+$95,000$190,000CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00002· FUNDING ONLY ACTION2023-10-26−$14,145$175,855CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00003· EXERCISE AN OPTION2023-11-07+$97,200$273,055CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-11-09+$0$273,055CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00005· OTHER ADMINISTRATIVE ACTION2024-05-30−$4,690$268,365CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00006· OTHER ADMINISTRATIVE ACTION2024-10-15+$101,250$369,615CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00007· EXERCISE AN OPTION2024-11-14+$97,200$466,815CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00008· OTHER ADMINISTRATIVE ACTION2025-05-01−$52,650$414,165CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-09-23+$101,250$515,415CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00010· EXERCISE AN OPTION2025-11-13+$198,450$713,865CU-64 DOTATATE RADIO-PHARMACEUTICAL
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-06-16+$0$713,865EO 14398 DEI DISCRIMINATION
Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-07-16−$32,400$681,465EO 14398 DEI DISCRIMINATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI EQ4VSLH8RC33)

AwardOffice · PSC / listingNet obligationsFY
36C24826N0411248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$231,773FY2026
36C24126N0274241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$771,411FY2026
36C25226N0210252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$164,999FY2026
36C26126N0065261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$153,991FY2026
36C24825N0208248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$224,563FY2025
36C24125N0495241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$656,883FY2025

Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0690SINA DRUG LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$188,463FY2026
36C24726N0211BOSTON SCIENTIFIC CORP247-NETWORK CONTRACT OFFICE 7 (36C247)$248,982FY2026
36C24726F0100AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$228,396FY2026
36C24726F0053EXELAN PHARMACEUTICALS INC247-NETWORK CONTRACT OFFICE 7 (36C247)$4,765,853FY2026
36C24726F0043AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$109,456FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24722P0498_3600_-NONE-_-NONE- · retrieved 2026-09-26.